Voyager Therapeutics, Inc. (VYGR)
USD 5.79
(-7.36%)
USD 5.79
(-7.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 250 Million | 40.9 Million | 37.41 Million | 171.12 Million | 104.39 Million | 7.61 Million |
| Cost of Revenue | 92.17 Million | 6.19 Million | 73.78 Million | 108.75 Million | 119.73 Million | 64.9 Million |
| Gross Profit | 157.83 Million | 34.71 Million | -36.37 Million | 62.37 Million | -15.34 Million | -57.28 Million |
| Operating Expenses | 35.82 Million | 91.74 Million | 111.03 Million | 143.74 Million | 156.07 Million | 98.71 Million |
| Selling, General and Administrative Expenses | 35.82 Million | 30.98 Million | 37.24 Million | 34.99 Million | 36.33 Million | 33.8 Million |
| Research and Development Expenses | 92.17 Million | 60.76 Million | 73.78 Million | 108.75 Million | 119.73 Million | 64.9 Million |
| Other Expenses | -92.17 Million | 4.44 Million | 2.42 Million | 7.69 Million | 8.08 Million | 2.62 Million |
| Cost and Expenses | 127.99 Million | 91.74 Million | 111.03 Million | 143.74 Million | 156.07 Million | 98.71 Million |
| Operating Income | 122.01 Million | -50.83 Million | -73.61 Million | 27.38 Million | -51.67 Million | -91.09 Million |
| Interest Expense | - | 1.79 Million | - | - | - | - |
| Income Tax Expense | 1.4 Million | 16 Thousand | -5.16 Million | -1.65 Million | -2.76 Million | -180 Thousand |
| Earnings before Tax | 133.73 Million | -46.39 Million | -71.19 Million | 36.74 Million | -43.59 Million | -88.46 Million |
| Net Income | 132.33 Million | -46.4 Million | -66.03 Million | 36.74 Million | -40.83 Million | -88.28 Million |
| Earnings Per Share Basic | 3.08 | -1.21 | -1.75 | 0.99 | -1.14 | -2.75 |
| Earnings Per Share Diluted | 2.97 | -1.21 | -1.75 | 0.98 | -1.14 | -2.75 |
| Weighted Average Shares Outstanding | 43.02 Million | 38.35 Million | 37.66 Million | 37.13 Million | 35.89 Million | 32.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.56 Million | 38.35 Million | 37.66 Million | 37.34 Million | 35.89 Million | 32.06 Million |
| Gross Margin | 0.63 | 0.85 | -0.97 | 0.36 | -0.15 | -7.52 |
| EBIT Margin | 0.51 | -1.24 | -1.97 | 0.18 | -0.50 | -11.96 |
| Profit Margin | 0.53 | -1.13 | -1.76 | 0.21 | -0.39 | -11.59 |
| EBITDA | 126.45 Million | -44.64 Million | -68.45 Million | 31.2 Million | -48.91 Million | -88.97 Million |
| Earnings Before Tax Margin | 0.49 | -1.24 | -1.97 | 0.16 | -0.50 | -11.96 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 29.57 Million | 19.51 Million | 90.06 Million | 250 Million | 4.61 Million | 4.85 Million |
| Cost of Revenue | 1.39 Million | 1.19 Million | 1.33 Million | 4.44 Million | 945 Thousand | 1.08 Million |
| Gross Profit | 28.18 Million | 18.32 Million | 88.72 Million | 245.56 Million | 3.66 Million | 3.76 Million |
| Operating Expenses | 43.21 Million | 34.5 Million | 34.66 Million | 123.55 Million | 34.12 Million | 30.27 Million |
| Selling, General and Administrative Expenses | 10.15 Million | 8.6 Million | 10.24 Million | - | 8.25 Million | 8.29 Million |
| Research and Development Expenses | 33.06 Million | 25.89 Million | 24.42 Million | - | 25.86 Million | 21.98 Million |
| Other Expenses | 20 Thousand | - | - | 3000.00 | - | 3000.00 |
| Cost and Expenses | 44.6 Million | 35.69 Million | 35.99 Million | 127.99 Million | 34.12 Million | 30.27 Million |
| Operating Income | -15.02 Million | -16.18 Million | 54.06 Million | 122.01 Million | -29.5 Million | -25.42 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 24 Thousand | 14 Thousand | 822 Thousand | 1.4 Million | -177 Thousand | 59 Thousand |
| Earnings before Tax | -10.11 Million | -11.31 Million | 57.21 Million | 133.73 Million | -26.07 Million | -22.14 Million |
| Net Income | -10.14 Million | -11.33 Million | 56.39 Million | 132.33 Million | -25.9 Million | -22.2 Million |
| Earnings Per Share Basic | -0.18 | -0.20 | 1.28 | - | -0.59 | -0.51 |
| Earnings Per Share Diluted | -0.18 | -0.20 | 1.25 | - | -0.59 | -0.51 |
| Weighted Average Shares Outstanding | 57.72 Million | 57.11 Million | 43.98 Million | 43.02 Million | 43.86 Million | 43.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.72 Million | 57.11 Million | 45.07 Million | 44.56 Million | 43.86 Million | 43.52 Million |
| Gross Margin | 0.95 | 0.94 | 0.99 | 0.98 | 0.80 | 0.78 |
| EBIT Margin | -0.46 | -0.77 | 0.62 | - | -6.19 | -5.02 |
| Profit Margin | -0.34 | -0.58 | 0.63 | 0.53 | -5.61 | -4.58 |
| EBITDA | -13.63 Million | -14.98 Million | 55.39 Million | - | -28.56 Million | -24.34 Million |
| Earnings Before Tax Margin | -0.51 | -0.83 | 0.60 | 0.49 | -6.40 | -5.24 |
1894
CENTUM
CEU
5303
FJTCY
COF-PN